Publication:
Risk management plans for biosimilar drugs

Simple item page
dc.contributor.authorsSardas, Semra
dc.date.accessioned2022-03-12T16:16:08Z
dc.date.accessioned2026-01-11T06:01:36Z
dc.date.available2022-03-12T16:16:08Z
dc.date.issued2016
dc.identifier.doi10.1016/j.toxlet.2016.06.1275
dc.identifier.eissn1879-3169
dc.identifier.issn0378-4274
dc.identifier.urihttps://hdl.handle.net/11424/225703
dc.identifier.wosWOS:000402436700145
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofTOXICOLOGY LETTERS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleRisk management plans for biosimilar drugs
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS49
oaire.citation.startPageS48
oaire.citation.titleTOXICOLOGY LETTERS
oaire.citation.volume258

Files

Collections

Araştırma Çıktıları